Know Cancer

or
forgot password
  • cancer clinical trials in rochester, NY

  • Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    University of Rochester

    Trial Locations
    University of Rochester
    Interlakes Foundation Inc-Rochester
    Highland Hospital
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    University of Rochester

    Trial Locations
    University of Rochester
    Interlakes Foundation Inc-Rochester
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    Highland Hospital of Rochester
    Rochester, New York 14620
    Prostate Cancer
    Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
    University of Rochester

    Trial Locations
    University of Rochester
    Highland Hospital
    Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Bronchoalveolar Cell Lung Cancer, Large Cell Lung Cancer, Squamous Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer
    S0530 Cytarabine and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Leukemia
    Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
    University of Rochester
    Rochester, New York 14642
    Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma, Adult Epithelioid Sarcoma, Adult Extraskeletal Chondrosarcoma, Adult Extraskeletal Osteosarcoma, Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Liposarcoma, Adult Malignant Fibrous Histiocytoma, Adult Malignant Hemangiopericytoma, Adult Malignant Mesenchymoma, Adult Neurofibrosarcoma, Adult Synovial Sarcoma, Childhood Alveolar Soft-part Sarcoma, Childhood Angiosarcoma, Childhood Epithelioid Sarcoma, Childhood Fibrosarcoma, Childhood Leiomyosarcoma, Childhood Liposarcoma, Childhood Malignant Mesenchymoma, Childhood Neurofibrosarcoma, Childhood Synovial Sarcoma, Chondrosarcoma, Dermatofibrosarcoma Protuberans, Localized Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia
    University of Rochester

    Trial Locations
    University of Rochester
    Interlakes Foundation Inc-Rochester
    Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer
    James P. Wilmot Cancer Center at University of Rochester Medical Center

    Trial Locations
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Highland Hospital of Rochester
    Lipson Cancer and Blood Center at Rochester General Hospital
    University Radiation Oncology at Parkridge Hospital
    Breast Cancer, Lung Cancer, Metastatic Cancer, Pain, Prostate Cancer
    Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Leukemia, Myelodysplastic Syndromes
    Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Leukemia
    S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
    Interlakes Oncology/Hematology PC

    Trial Locations
    Interlakes Oncology/Hematology PC
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Lymphoma
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Interlakes Oncology/Hematology PC

    Trial Locations
    Interlakes Oncology/Hematology PC
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Lipson Cancer and Blood Center at Rochester General Hospital
    Breast Cancer
    A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
    Site Reference ID/Investigator# 12306
    Rochester, New York 14642
    Chronic Lymphoid Leukemia, Lymphoid Malignancies, Non-Hodgkin's Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Peripheral T-cell Lymphoma
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
    University of Rochester
    Rochester, New York 14642
    Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, T-cell Adult Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone
    Interlakes Oncology/Hematology PC

    Trial Locations
    Interlakes Oncology/Hematology PC
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Breast Cancer, Metastatic Cancer
    Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Prostate Cancer
    Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
    University of Rochester

    Trial Locations
    University of Rochester
    Highland Hospital
    Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Highland Hospital
    Rochester, New York 14620
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Bladder Cancer
    S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer
    Interlakes Oncology/Hematology PC

    Trial Locations
    Interlakes Oncology/Hematology PC
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Highland Hospital of Rochester
    Lung Cancer
    A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
    Helendale Dermatology & Medical Spa, LLC
    Rochester, New York 14609
    Atopic Dermatitis
    Assessment Tool for Older Patients With Cancer
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Cognitive/Functional Effects, Psychosocial Effects of Cancer and Its Treatment, Unspecified Adult Solid Tumor, Protocol Specific
    Adj TC + Herceptin Early Stage Breast Cancer
    Interlakes Oncology Hematology, PC
    Rochester, New York 14623
    Breast Cancer
    TAC Versus TC for Adjuvant Breast Cancer
    Interlakes Oncology Hematology, PC
    Rochester, New York 14623
    Breast Cancer
    Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Lung Cancer
    Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Neuroblastoma
    Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Leukemia
    Docetaxel+Oxali+/-Cetux Met Gastric/GEJ
    Interlakes Oncology Hematology, PC
    Rochester, New York 14623
    Metastatic Gastric or GEJ Cancer
    First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
    University of Rochester

    Trial Locations
    University of Rochester
    Interlakes Foundation Inc-Rochester
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
    Highland Hospital of Rochester

    Trial Locations
    Highland Hospital of Rochester
    University Radiation Oncology at Parkridge Hospital
    Lung Cancer, Radiation Toxicity